1. 1. Van Der Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 17: 356-363, 2010.
2. 2. Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci 66: 302-309, 1970.
3. 3. Wegener DA, Suzuki K, Suzuki Y, et al. Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease). In: The Metabolic & Molecular Basis of Inherited Disease. 8th ed. Scriver R, Beaudet AL, Sly WS, et al., Eds. McGraw-Hill, New York, 2001: 3669-3694.
4. 4. Hossain MA, Otomo T, Saito S, et al. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form. Gene 534: 144-154, 2013.
5. 5. Rita DG, Miguel AGS, Edi LS, et al. Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy. Am J Hum Genet 59: 1233-1242, 1996.